Abstract
ABSTRACT Parkinson disease (PD) is a complex movement disorder in which the symptomatology, severity and progression vary substantially among patients. Therefore, there is a need to individualize patient therapy. Factors that should be considered when individualizing therapy include published guidelines, practice parameters, and Evidence Based Medicine (EBM) reviews, as well as clinical experience and judgment, patient specific factors and preferences, consensus and expert opinions, and health economic constraints. This article discusses EBM findings regarding treatment of the motor symptoms and the non-motor symptoms associated with PD.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have